UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering commercial, clinical, communications and packaging services to the healthcare industry, employing over 9,000 people with operations in 24 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.  


Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industry. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides Healthcare brand advisory, consulting and commercial audit services. Scientific communication content, behavioural change strategies, digital and creative patient-centred services. Commercialisation and clinical services including sales representatives, nursing services, contact centres and meetings and events to over 300 healthcare companies in 23 countries.


Sharp is a global leader in contract packaging and clinical trial supply services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. 


Aquilant is a leading expert and provider of outsourced services to the medical and scientific sectors in the UK, Ireland and the Netherlands.


The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

  • Top 30 pharma companies are all customers
  • €943.1 million 2016 revenue
  • €104.2 million 2016 operating profit
  • 25+ years dividend growth
  • Video
  • UDG Healthcare
02 May 2017

Introduction to UDG Healthcare

Watch video

Download our Factsheet

Key facts

Where we operate

Read more